Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000426BKPyvENSG00000176105.14protein_codingYES1YesNo7525P07947
TVIS10039389HBVENSG00000176105.14protein_codingYES1YesNo7525P07947
TVIS30007287HIVENSG00000176105.14protein_codingYES1YesNo7525P07947
TVIS30007288HIVENSG00000176105.14protein_codingYES1YesNo7525P07947
TVIS20053411HPVENSG00000176105.14protein_codingYES1YesNo7525P07947
TVIS20015749HPVENSG00000176105.14protein_codingYES1YesNo7525P07947
TCGA Plot Options
Drug Information
GeneYES1
DrugBank IDDB01254
Drug NameDasatinib
Target IDBE0000840
UniProt IDP07947
Regulation Typeinhibitor
PubMed IDs16507911; 17541990; 20072833
CitationsTrevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY, Donato NJ, Abbruzzese JL, Baker CH, Gallick GE: Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol. 2006 Mar;168(3):962-72.@@Margutti S, Laufer SA: Are MAP kinases drug targets? Yes, but difficult ones. ChemMedChem. 2007 Aug;2(8):1116-40.@@Lindauer M, Hochhaus A: Dasatinib. Recent Results Cancer Res. 2010;184:83-102. doi: 10.1007/978-3-642-01222-8_7.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
PathwaysDasatinib Inhibition of BCR-ABL
PharmGKBPA162372878
ChEMBLCHEMBL1421